Table 3.
Comparison of 3-year survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy, n (%)
|
Group
|
Number of cases (n)
|
1 year
|
2 years
|
3 years
|
| Effective group | 121 | 113 (93.39) | 101 (83.47) | 73 (60.33) |
| Effective group | 64 | 45 (70.31) | 23 (35.94) | 18 (28.13) |
| χ² value | 7.921 | 8.691 | 6.536 | |
| P value | 0.012 | 0.004 | 0.025 |